CV Disease in Special Populations

Martha Gulati,

Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg, et al

Watch time: 14s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi,

Watch time: 23m 6s
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT

David Austin,

Watch time: 3m 37s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s

Kevin Lee , Iva Minga , Eryn Cameron , et al

Read time: 8m

Daniel Lenihan, , , et al

Watch time: 53m 54s

Daniel Lenihan, , , et al

Watch time: 58m 27s

Daniel Lenihan, , , et al

Watch time: 1h 7m 36s

Daniel Lenihan, ,

Watch time: 1h 1m 32s
ACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial

Marielle Scherrer-Crosbie,

Watch time: 5m 59s
ACC 23: The LIVE-HCM Trial

Rachel Lampert, Michael Ackerman, Sharlene Day, et al

Watch time: 6m 25s

Heather Currie , Christine Williams ,

Read time: 10m

Raymond B Fohtung , Michael W Rich ,

Kimberly Atianzar , Peter Casterella , Ming Zhang , et al

William E Hellenbrand ,

Jonathan N Johnson , Frank Cetta ,

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Keith C Ferdinand ,

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Lydia Taranto , Tabitha Moe ,

Saumil R Shah , Sergio Waxman , William H Gaasch ,

Marc G Cribbs ,

Ijeoma Isiadinso , Nanette K Wenger ,

Read time: 15m

Media

Daniel Lenihan, , , et al

Watch time: 53m 54s

Daniel Lenihan, , , et al

Watch time: 58m 27s

Daniel Lenihan, , , et al

Watch time: 1h 7m 36s

Daniel Lenihan, ,

Watch time: 1h 1m 32s
ACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial

Marielle Scherrer-Crosbie,

Watch time: 5m 59s

Watch time: 3h 52m 31s

Neha Bansal, Joshua Mitchell, Avirup Guha, et al

Watch time: 56m 19s (7 videos)
Cardio-oncology A-Z: Late Effects Cardiotoxicity

Neha Bansal,

Watch time: 8m 22s
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

Watch time: 8m 19s
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups

David Lanfear,

Watch time: 5m 27s
Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed,

Watch time: 29m 19s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 36m 1s

Media

Martha Gulati,

Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg, et al

Watch time: 14s
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT

David Austin,

Watch time: 3m 37s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi,

Watch time: 23m 6s

Daniel Lenihan, ,

Watch time: 1h 1m 32s
Masterclass on The Global Burden of CV Disease in Women

Birgit Vogel, Harriette Van Spall,

Watch time: 20m 32s
ESC 23: The ONCO DVT Study

Yugo Yamashita,

Watch time: 4m 8s

Daniel Lenihan, , , et al

Watch time: 53m 54s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Neha Bansal, Joshua Mitchell, Avirup Guha, et al

Watch time: 56m 19s (7 videos)
Cardio-oncology A-Z: Breast Cancer Treatment Related Cardiotoxicity With Dr Anne Blaes

Watch time: 10m

Daniel Lenihan, , , et al

Watch time: 58m 27s

Articles

Cardiac Toxicity of Cancer Chemotherapy

Aarti Asnani

,

Randall T Peterson

,

Citation:

US Cardiology Review 2017;11(1):20–4

DOI:

https://doi.org/10.15420/usc.2017:2:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3839
  • Downloads: Downloads 25
  • Citations: 1

Do We Need a Different Approach to Assess Cardiovascular Risk in Women?

Ijeoma Isiadinso

,

Nanette K Wenger

,

Citation:

US Cardiology Review 2017;11(1):5–9

DOI:

https://doi.org/10.15420/usc.2016:8:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3943
  • Downloads: Downloads 25
  • Citations: 8
  • Read time: 15m

Identification of Patients at Risk of Stroke From Atrial Fibrillation

Raymond B Fohtung

,

Michael W Rich

,

Citation:

US Cardiology Review 2016;10(2):60–4

DOI:

https://doi.org/10.15420/usc.2016:1:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 11209
  • Downloads: Downloads 29
  • Citations: 10

American Heart Association's Shared Focus is Critical to Achieving its Goals Faster

Robert Eckel

,

Citation:

US Cardiology 2005;2(1):18–9

DOI:

https://doi.org/10.15420/usc.2005.2.1.18
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 320
  • Downloads: Downloads 1